Novartis (NVS) Plans to Ship 30 Million Doses of Influenza Vaccine

Article Stock Quotes (1) Comments (0)

Novartis (NYSE: NVS) has commenced shipment of its seasonal influenza vaccine to customers in the US for the 2012-2013 influenza season. The early arrival of seasonal influenza vaccines will ensure healthcare professionals are equipped to provide the earliest possible protection against influenza. This year, Novartis plans to ship more than 30 million doses of the vaccine, which has been reformulated to include two new influenza strains to meet the updated World Health Organization and US Food and Drug Administration (FDA) recommendations. Fluvirin® has been approved by FDA for persons 4 years of age and older2.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Acacia Research (ACTG) Enters Settlement with Red Hat (RHT)
• Apricus Bio (APRI) Prices 6M Common Stock Offering
• Sprint (S), SoftBank Receive Final State Regulatory Approval in Proposed Deal

Create E-mail Alert Related Categories

Corporate News

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?